Ovarian Neoplasms: all 2,757 studies
Page 20 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing SurgeryCompletedNCT03011320Phase 1
- Fluid Balance During Surgery for Ovarian CancerStatus unknownNCT03006939
- Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125CompletedNCT03004391
- HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday LifeStatus unknownNCT03000192
- Fluorescence for Sentinel Lymph Node Identification in Cancer SurgeryCompletedNCT02997553Phase 3
- Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast CancerCompletedNCT02996825Phase 1
- Exercise Effect on Chemotherapy-Induced Neuropathic PainActive, not recruitingNCT02991677Not applicable
- FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic StudyCompletedNCT02984423
- Determinants of Age-Related Treatment Effectiveness in Ovarian CancerCompletedNCT02973750
- BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian CancerCompletedNCT02963688
- EURAD MRI Classification of US Indeterminate Adnexa LesionsCompletedNCT02962596
- A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsStatus unknownNCT02950064Phase 1
- Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With ChemotherapyCompletedNCT02948075Phase 2
- HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell CarcinomaTerminatedNCT02947152Phase 1
- Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian CancerTerminatedNCT02943317Phase 1
- Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian CarcinomaTerminatedNCT02933073Phase 1
- Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative StudyCompletedNCT02928549
- Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesActive, not recruitingNCT02917798
- Individual Survivorship Program for Ovarian Cancer Patients Based on PROM's and Shared Decision MakingCompletedNCT02916875
- Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer.CompletedNCT02910622
- Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype PatientsCompletedNCT02903004Phase 3
- CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceTerminatedNCT02900248
- ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+BevacizumabCompletedNCT02891824Phase 3
- Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look SurgeryActive, not recruitingNCT02884648Phase 2
- Study of Predictive Factors of Chemoresistance in Ovarian CancerCompletedNCT02878122
- Mobile Phone Technology to Increase Genetic CounselingCompletedNCT02877862Not applicable
- PET Imaging of Ovarian Carcinoma With 18F-FSPGWithdrawnNCT02872519Early Phase 1
- Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsActive, not recruitingNCT02869217Phase 1
- Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian CancerCompletedNCT02867956Phase 2
- Intra-peritoneal Chemotherapy in Ovarian CancerStatus unknownNCT02861872
- Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients with Advanced Ovarian Cancer (SUNNY)Active, not recruitingNCT02859038Phase 3
- The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian CancerCompletedNCT02856841
- Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian CancerCompletedNCT02855697Early Phase 1
- Cost Utility of Radical Surgery in Ovarian CancerCompletedNCT02854215Not applicable
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian CancerCompletedNCT02849353Phase 1/2
- Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to SurgeryStatus unknownNCT02847832
- Value of MRI in the Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple RulesStatus unknownNCT02836275Not applicable
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02833506Phase 1
- Trial on Radical Upfront Surgery in Advanced Ovarian CancerActive, not recruitingNCT02828618Not applicable
- Ovarian Cancer Hemoscope TrialActive, not recruitingNCT02811224
- Improving Quality of Care for Patients With Recurrent Ovarian CancerStatus unknownNCT02809339
- Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian CancerCompletedNCT02788708Phase 1
- Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving ChemotherapyCompletedNCT02786524Not applicable
- Identification and Referral of Women at Risk for Hereditary Breast/Ovarian CancerCompletedNCT02786147
- Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology PatientsCompletedNCT02785887Not applicable
- Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.CompletedNCT02785731
- Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian CancerActive, not recruitingNCT02785250Phase 1/2
- Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.CompletedNCT02781272
- Physician-Patient Communication and Expectations Regarding Ovarian Cancer PrognosisTerminatedNCT02769546
- Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian CancerActive, not recruitingNCT02758652
- Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)WithdrawnNCT02756130Phase 1/2
- Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant CancerCompletedNCT02751918Phase 1
- A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian CancerCompletedNCT02737787Phase 1
- Use of Regorafenib in Recurrent Epithelial Ovarian CancerCompletedNCT02736305Phase 2
- Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and TaxaneCompletedNCT02728622Phase 3
- Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With ChemotherapyCompletedNCT02728492Phase 1
- Pilot Study of Durvalumab and Vigil in Advanced Women's CancersCompletedNCT02725489Phase 2
- Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective StudyStatus unknownNCT02719041
- Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian CancerStatus unknownNCT02711865
- Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC RiskTerminatedNCT02705924Not applicable
- Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)CompletedNCT02704832Not applicable
- Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal FluidsWithdrawnNCT02704650Not applicable
- The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal CancerStatus unknownNCT02687321
- Treatment for Malignant Ovarian Cancer: Laparoscopy vs LaparotomyStatus unknownNCT02686463Not applicable
- Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian CancerStatus unknownNCT02681432Phase 3
- A Study of Cediranib and Olaparib at Disease Worsening in Ovarian CancerCompletedNCT02681237Not applicable
- STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian CancerCompletedNCT02676726Not applicable
- Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian CancerCompletedNCT02672098Phase 1
- Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian OriginWithdrawnNCT02667925Not applicable
- Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary PresentationTerminatedNCT02664389Not applicable
- Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian CancerCompletedNCT02659384Phase 2
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
- Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial CancersStatus unknownNCT02638402
- Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.CompletedNCT02610075Phase 1
- HE4 as a Relapse Biomarker in Ovarian CancersCompletedNCT02595281Not applicable
- Total/Subtotal Colectomy in Ovarian CancerStatus unknownNCT02595021Phase 2
- Writing About Experiences With Ovarian CancerCompletedNCT02593422Not applicable
- A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian CancerCompletedNCT02591095Phase 2
- REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological ProgressionCompletedNCT02584465Phase 2
- MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian CancerCompletedNCT02582931Phase 1
- Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoStatus unknownNCT02580747Phase 1
- Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic MalignanciesCompletedNCT02578888Not applicable
- PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian CancerActive, not recruitingNCT02571725Phase 1/2
- The SOCQER-2 Study Surgery in Ovarian Cancer - Quality of Life Evaluation ResearchCompletedNCT02569983
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
- Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
- Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian CancerCompletedNCT02567253Phase 2
- Adjuvant Chemotherapy of Three-step Regimen in Ovarian CancerStatus unknownNCT02562365Phase 2
- Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian CancerCompletedNCT02560818Not applicable
- Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.CompletedNCT02560337Phase 2
- Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian CancerStatus unknownNCT02545010Phase 1
- Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133CompletedNCT02541370Phase 1/2
- Sentinel Node Detection in Ovarian CancerTerminatedNCT02540551Phase 1
- Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian CancerTerminatedNCT02539719Phase 1
- Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian CancerStatus unknownNCT02534922Phase 1
- A Mind-body Intervention to Improve Body and/or Self ImageCompletedNCT02531997Not applicable
- Mesenchymal Stem Cells (MSC) for Ovarian CancerCompletedNCT02530047Phase 1
- WISER After Ovarian Cancer - Exercise Pilot StudyCompletedNCT02529150Not applicable
- Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial CancerStatus unknownNCT02524808